Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Academic Article uri icon

Overview

abstract

  • Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.

publication date

  • April 2, 2020

Research

keywords

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Betacoronavirus
  • Coronavirus
  • Coronavirus Infections
  • Pneumonia, Viral

Identity

PubMed Central ID

  • PMC7129017

Scopus Document Identifier

  • 85082822449

Digital Object Identifier (DOI)

  • 10.1016/j.it.2020.03.007

PubMed ID

  • 32249063

Additional Document Info

volume

  • 41

issue

  • 5